Literature DB >> 2448450

The effects of the calcium channel agonist, Bay K-8644, on guinea-pig ileum and rat uterine horn.

D Conte-Camerino1, M D Lograno, A de Luca, M Perischella, F Franconi.   

Abstract

Bay K-8644 (methyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(2- trifluoromethylphenyl)pyridine-5-carboxylate) concentration-dependently caused contractions of the partly depolarized ileum, but at higher concentrations (10(-6) to 10(-5) M) produced relaxation. 10(-8) to 4 X 10(-7) M nifedipine antagonized while 10(-9) and 4 X 10(-9) M potentiated Bay K-8644. On the partly depolarized uterus, Bay K-8644 (10(-9) to 10(-6) M) had only a spasmogenic effect whereas nifedipine (4 X 10(-9) to 10(-7) M) was spasmolytic. Verapamil and diltiazem (each at 10(-4) M) both reduced the maximal response to Bay K-8644, while other spasmolytics were ineffective. Thus, Bay K-8644 activates ileum and uterus by opening voltage-operated Ca2+ channels, but its relaxant action at high concentration and its potentiation by nifedipine is not seen in both organs. Such differences probably depend on the concentration of the compounds used and the polarization state of the cell membranes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2448450     DOI: 10.1111/j.2042-7158.1987.tb03139.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  3 in total

1.  Cellular localization of the inhibitory action of relaxin against uterine spasm.

Authors:  S J Hughes; M Hollingsworth
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

2.  Role of L-type calcium channels on yohimbine-precipitated clonidine withdrawal in vivo and in vitro.

Authors:  M Barrios; I Robles; J M Baeyens
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-12       Impact factor: 3.000

3.  Effect of nifedipine on mouth-to-cecum transit of liquid meal in normal subjects.

Authors:  G Chiarioni; C Scattolini; F Bonfante; M T Brentegani; I Vantini
Journal:  Dig Dis Sci       Date:  1993-06       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.